Himalaya Drug Company Private Limited, a active private limited company, was established on 21 May 1997 in Nelamangala, Karnataka, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U24232KA1997PTC022261. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Jayashree Ullal (Director), Karagadde Ganapathi Umesh (Director), Syed Farooq Ahmed (Director). Past directors included Meraj Alim Manal, Karagadde Ganapathi Umesh, Philipe Joseph Haydon. It holds ₹161.61 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Makali, Tumkur Road, Nelamangala, Karnataka, 562162.
U24232KA1997PTC022261
022261
21 May 1997
₹5.00 M
₹1.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Himalaya Drug Company Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayashree Ullal | Director | 09 Jan 2009 | Current |
| Karagadde Ganapathi Umesh | Director | 31 Aug 2020 | Current |
| Syed Farooq Ahmed | Director | 31 Oct 1997 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 31 Aug 2020 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 09 Jan 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Himalaya Drug Company Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.34% increase. The company also saw a slight decrease in profitability, with a 0.31% decrease in profit. The company's net worth Soared by an impressive increase of 23.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Himalaya Drug Company had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,616,071,435.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2006 | Union Bank Of India | ₹161.61 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Himalaya Drug Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Himalaya Drug Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Himalaya Drug Company's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Himalaya Drug Company Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Himalaya Drug Company Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Progress on Karagadde Ganapathi Umesh was appointed as a Director was appointed as a Director on 31 Aug 2020 & has been associated with this company since 5 years 3 months . was documented.
A charge with Union Bank Of India of Rs. 1,616.07 M registered on 27 Mar 2006 with Charge ID 10043583 was modified on 21 Sep 2013. was recorded as a recent event.
Jayashree Ullal was appointed as a Director was appointed as a Director on 09 Jan 2009 & has been associated with this company since 16 years 10 months . was recorded as a recent event.
Progress on A charge with Union Bank Of India amounted to Rs. 1,616.07 M with Charge ID 10043583 was registered on 27 Mar 2006. was documented.
With Groundbreaking of AED 200 million Herbal Pharmaceutical Factory at Dubai Industrial City.
Himalaya Wellness Company introduces all new crème Cleansing BABY BAR .
The CIN of Himalaya Drug Company Private Limited is U24232KA1997PTC022261.
Himalaya Drug Company Private Limited is headquartered at Makali, Tumkur Road, Nelamangala, Karnataka, 562162.
Himalaya Drug Company Private Limited was incorporated on 21 May 1997.
The current directors of Himalaya Drug Company Private Limited are
The primary industry of Himalaya Drug Company Private Limited is Manufacturing.
Himalaya Drug Company Private Limited is unlisted.
The authorized capital of Himalaya Drug Company Private Limited is ₹5.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Himalaya Drug Company Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX